Hemispherx Biopharma Inc (NYSE American:HEB)

0.5277
Delayed Data
As of Feb 23
 +0.0427 / +8.80%
Today’s Change
0.30
Today|||52-Week Range
0.84
+52.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues16.0K84.0K213.0K90.0K
 
 
 
 
 
Cost of Goods Sold116.0K133.0K94.5K133.0K
 
 
 
 
 
Depreciation And Amortization324.0K274.0K247.0K266.0K
 
 
 
 
 
 
Operating ExpensesGross Income-424.0K-323.0K-128.5K-309.0K
 
 
 
 
 
General Expenses3.7M2.9M2.6M2.3M
 
 
 
 
 
Research And Development1.9M1.4M1.1M787.0K
 
 
 
 
 
Total Operating Expenses4.1M3.3M2.9M2.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.1M-3.2M-2.7M-2.7M
 
 
 
 
 
Extraordinary Credit1.6M393.0K529.0K1.4M
 
 
 
 
 
Interest Expense On Debt0.000.0019.0K51.0K
 
 
 
Other Expenses1.3M1.0K6.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-2.8M-2.2M-1.3M
 
 
 
 
 
Net Income-1.2M-2.8M-2.2M-1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.2M25.3M27.3M30.1M
 
 
 
 
 
Shares To Calculate EPS Diluted24.2M25.3M27.3M30.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.11-$0.08-$0.04
 
 
 
 
 
EPS Diluted-$0.05-$0.11-$0.08-$0.04